Cat allergy study sniffs out new insights
NCT ID NCT06828484
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to see if a special cat allergen extract (AP Cat) can cause hay fever symptoms when sprayed into the nose of people with cat allergies. Twenty volunteers—some allergic to cats, some not—will receive the extract and have their symptoms and allergy markers measured. The goal is to better understand how cat allergies work, not to test a treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Acetone-precipitated cat hair allergen extract (AP Cat)
- What this could lead to
- If successful, this could provide a reliable model for studying cat allergies and testing future treatments.
- What could go wrong
- This is a small, early-phase study with only 20 participants, so results may not apply broadly. It is designed to observe responses, not to treat or cure allergies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kingston Health Sciences Centre - Kingston General Hospital
Kingston, Ontario, K7L2V7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ancient herbal blend put to the test against hay fever
- Can a pinpoint pollen dose unmask allergy triggers?
- Can an antihistamine–steroid combo pill beat standard allergy meds?
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Allergy study seeks to pinpoint those most bothered by cats and birch pollen
- Dog allergy vaccine shows promise in small swedish trial